Metformin and Resveratrol Inhibit Drp1-Mediated Mitochondrial Fission and Prevent ER Stress-Associated NLRP3 Inflammasome Activation in the Adipose Tissue of Diabetic Mice
Abstract
Objective This study was designed to investigate the hypothesis that metformin and resveratrol exhibited the same effect on inhibition of NLRP3 inflammasome activation with regulation of AMPK in adipose tissue exposed to high glucose.Methods To induce adipose tissue dysfunction, we treated epididymal adipose tissue of mice or differentiated 3T3-L1 adipocytes with high glucose (33 mM) for 24 h. Meanwhile, mice were injected with streptozotocin STZ to induce diabetes and followed by oral administration of metformin (200 mg/kg), resveratrol (50 mg/kg) or ER stress inhibitor TUDCA (50 mg/kg) for 7 days. The effects of metformin and resveratrol on ROS production, mitochondrial fission, ER stress, TXNIP/NLRP3 inflammasome activation, inflammation and apoptosis were observed.Results Metformin and resveratrol inhibited ROS-associated mitochondrial fission by upregulating Drp1 phosphorylation (Ser 637) in an AMPK-dependent manner, and then suppressed ER stress indicated by dephosphorylation of IRE1α and eIF2α in the adipose tissue. As a result from suppressing TXNIP/NLRP3 inflammasome activation, metformin and resveratrol inhibited inflammation and reduced cell apoptosis in adipose tissue or adipocytes exposed to high glucose.Conclusion Metformin and resveratrol protected mitochondrial integrity by inhibiting Drp1 activity and prevented NLRP3 inflammasome activation by suppressing ER stress, and thereby protected adipose function from high glucose insult.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Both metformin and resveratrol inhibit ROS-associated mitochondria fission.
“Interestingly, both metformin and the anti-oxidant, resveratrol, inhibit ROS-associated mitochondria fission (152).”
From A Critical Review of the Evidence That Metformin Is a Putative Anti-Aging Drug That Enhances Healthspan and Extends Lifespan (2021) · cites this paper as [152]
Cites
Biochemistry and molecular cell biology of diabetic complications
Brownlee, M. (2001) · Nature · doi:10.1038/414813a · Cited by 9,107 · see citing works
THE MAMMALIAN UNFOLDED PROTEIN RESPONSE
Schröder, M., & Kaufman, R. J. (2005) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.73.011303.074134 · Cited by 3,035 · see citing works
Thioredoxin-interacting protein links oxidative stress to inflammasome activation
Zhou, R., Tardivel, A., Thorens, B., Choi, I., & Tschopp, J. (2010) · Nature Immunology · doi:10.1038/ni.1831 · Cited by 2,708 · see citing works
From endoplasmic-reticulum stress to the inflammatory response
Zhang, K., & Kaufman, R. J. (2008) · Nature · doi:10.1038/nature07203 · Cited by 2,010 · see citing works
Dynamin-related Protein Drp1 Is Required for Mitochondrial Division in Mammalian Cells
Smirnova, E., Griparić, L., Shurland, D., & van der Bliek, A. M. (2001) · Molecular Biology of the Cell · doi:10.1091/mbc.12.8.2245 · Cited by 1,938 · see citing works
Endoplasmic Reticulum Stress and Oxidative Stress: A Vicious Cycle or a Double-Edged Sword?
Malhotra, J., & Kaufman, R. (2007) · Antioxidants and Redox Signaling · doi:10.1089/ars.2007.1782 · Cited by 1,507 · see citing works
Mitochondrial Dynamics — Mitochondrial Fission and Fusion in Human Diseases
Archer, S. L. (2013) · New England Journal of Medicine · doi:10.1056/nejmra1215233 · Cited by 1,103 · see citing works
AMP-activated protein kinase mediates mitochondrial fission in response to energy stress
Toyama, E. Q., Herzig, S., Courchet, J., Lewis, T. L., Losón, O. C., Hellberg, K., Young, N. P., Chen, H., Polleux, F., Chan, D. C., et al. (2016) · Science · doi:10.1126/science.aab4138 · Cited by 1,085 · see citing works
Wisse, B. E. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000141966.69934.21 · Cited by 927 · see citing works
Lerner, A. G., Upton, J.-P., Praveen, P. V. K., Ghosh, R., Nakagawa, Y., Igbaria, A., Shen, S., Nguyen, V. Q., Backes, B. J., Heiman, M., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.07.007 · Cited by 841 · see citing works
Oslowski, C. M., Hara, T., O’Sullivan-Murphy, B., Kanekura, K., Lu, S., Hara, M., Ishigaki, S., Zhu, L. J., Hayashi, E., Hui, S. T. Y., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.07.005 · Cited by 678 · see citing works
A Molecular Web: Endoplasmic Reticulum Stress, Inflammation, and Oxidative Stress
Chaudhari, N., Talwar, P., Parimisetty, A., Lefebvre d’Hellencourt, C., & Ravanan, P. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00213 · Cited by 600 · see citing works
Prevention of mitochondrial oxidative damage as a therapeutic strategy in diabetes
Green, K., Brand, M. D., & Murphy, M. P. (2004) · Diabetes · doi:10.2337/diabetes.53.2007.s110 · Cited by 490 · see citing works
Hattori, Y., Suzuki, K., Hattori, S., & Kasai, K. (2006) · Hypertension · doi:10.1161/01.hyp.0000221429.94591.72 · Cited by 487 · see citing works
Endoplasmic Reticulum Stress and Inflammation in Obesity and Diabetes
Hummasti, S., & Hotamışlıgil, G. S. (2010) · Circulation Research · doi:10.1161/circresaha.110.225698 · Cited by 436 · see citing works
Obesity-induced endoplasmic reticulum stress causes chronic inflammation in adipose tissue
Kawasaki, N., Asada, R., Saito, A., Kanemoto, S., & Imaizumi, K. (2012) · Scientific Reports · doi:10.1038/srep00799 · Cited by 404 · see citing works
Zeyda, M., & Stulnig, T. M. (2007) · Immunology Letters · doi:10.1016/j.imlet.2007.07.003 · Cited by 307 · see citing works
Yu, T., Jhun, B. S., & Yoon, Y. (2010) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3284 · Cited by 286 · see citing works
Ashabi, G., Khalaj, L., Khodagholi, F., Goudarzvand, M., & Sarkaki, A. (2014) · Metabolic Brain Disease · doi:10.1007/s11011-014-9632-2 · Cited by 256 · see citing works
Li, J., Wang, Y., Wang, Y., Wen, X., Ma, X., Chen, W., Huang, F., Kou, J., Qi, L., Liu, B., et al. (2015) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2015.07.010 · Cited by 182 · see citing works
Obesity-Related Upregulation of Monocyte Chemotactic Factors in Adipocytes
Jiao, P., Chen, Q., Shah, S., Du, J., Bo, T., Tzameli, I., Yan, W., & Xu, H. (2008) · Diabetes · doi:10.2337/db07-1344 · Cited by 165 · see citing works
AMPK Regulates ER Morphology and Function in Stressed Pancreatic β-Cells via Phosphorylation of DRP1
Wikström, J. D., Israeli, T., Bachar-Wikström, E., Swisa, A., Ariav, Y., Waiss, M., Kaganovich, D., Dor, Y., Cerasi, E., & Leibowitz, G. (2013) · Molecular Endocrinology · doi:10.1210/me.2013-1109 · Cited by 119 · see citing works
Chang, C. (2012) · The Chinese Journal of Physiology · doi:10.4077/cjp.2012.baa012 · Cited by 91 · see citing works
Sun, Y., Li, J., Xiao, N., Wang, M., Kou, J., Qi, L., Huang, F., Liu, B., & Liu, K. (2014) · Pharmacological Research · doi:10.1016/j.phrs.2014.07.006 · Cited by 90 · see citing works
Resveratrol inhibits TNF-α-induced changes of adipokines in 3T3-L1 adipocytes
Ahn, J., Lee, H., Kim, S., & Ha, T. Y. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.10.109 · Cited by 89 · see citing works
Molecular Targets of Diabetic Cardiovascular Complications
Ahmad, F. K., He, Z., & King, G. L. (2005) · Current Drug Targets · doi:10.2174/1389450054021990 · Cited by 81 · see citing works
The Phosphorylation-Dependent Regulation of Mitochondrial Proteins in Stress Responses
Kanamaru, Y., Sekine, S., Ichijo, H., & Takeda, K. (2012) · Journal of Signal Transduction · doi:10.1155/2012/931215 · Cited by 56 · see citing works
TXNIP Switches Tracks toward a Terminal UPR
Anthony, T. G., & Wek, R. C. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.07.012 · Cited by 47 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
The cell biology of mitochondrial membrane dynamics
Giacomello, M., Pyakurel, A., Glytsou, C., & Scorrano, L. (2020) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-0210-7 · Cited by 1,550 · see citing works
NLRP3 inflammasome activation and cell death
Huang, Y., Xu, W., & Zhou, R. (2021) · Cellular & Molecular Immunology · doi:10.1038/s41423-021-00740-6 · Cited by 1,527 · see citing works
Mitochondrial dynamics in type 2 diabetes: Pathophysiological implications
Rovira-Llopis, S., Bañuls, C., Diaz-Morales, N., Hernandez-Mijares, A., Rocha, M., & Victor, V. M. (2017) · Redox Biology · doi:10.1016/j.redox.2017.01.013 · Cited by 657 · see citing works
AMPK as a Therapeutic Target for Treating Metabolic Diseases
Day, E. A., Ford, R. J., & Steinberg, G. R. (2017) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2017.05.004 · Cited by 620 · see citing works
Xian, H., Liu, Y., Nilsson, A. R., Gatchalian, R., Crother, T. R., Tourtellotte, W. G., Zhang, Y., Alemán-Muench, G. R., Lewis, G. M., Chen, W., et al. (2021) · Immunity · doi:10.1016/j.immuni.2021.05.004 · Cited by 407 · see citing works
Health Benefits and Molecular Mechanisms of Resveratrol: A Narrative Review
Meng, X., Zhou, J., Zhao, C.-N., Gan, R.-Y., & Li, H.-B. (2020) · Foods · doi:10.3390/foods9030340 · Cited by 387 · see citing works
Wang, Q., Zhang, M., Torres, G., Wu, S., Ouyang, C., Xie, Z., & Zou, M.-H. (2017) · Diabetes · doi:10.2337/db16-0915 · Cited by 370 · see citing works
TXNIP: A key protein in the cellular stress response pathway and a potential therapeutic target
Choi, E.-H., & Park, S.-J. (2023) · Experimental & Molecular Medicine · doi:10.1038/s12276-023-01019-8 · Cited by 350 · see citing works
Pyroptosis, metabolism, and tumor immune microenvironment
Du, T., Gao, J., Li, P., Wang, Y., Qi, Q., Liu, X., Li, J., Wang, C., & Du, L. (2021) · Clinical and Translational Medicine · doi:10.1002/ctm2.492 · Cited by 325 · see citing works
A comprehensive review of the health perspectives of resveratrol
Rauf, A., Imran, M., Suleria, H. A. R., Ahmad, B., Peters, D. G., & Mubarak, M. S. (2017) · Food & Function · doi:10.1039/c7fo01300k · Cited by 286 · see citing works
Mohammed, I., Hollenberg, M. D., Ding, H., & Triggle, C. R. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.718942 · Cited by 278 · see citing works
Modulatory Mechanisms of the NLRP3 Inflammasomes in Diabetes
Ding, S., Xu, S., Ma, Y., Liu, G., Jang, H., & Fang, J. Q. (2019) · Biomolecules · doi:10.3390/biom9120850 · Cited by 241 · see citing works
Davidson, S. M., Adameová, A., Barile, L., Cabrera-Fuentes, H. A., Lazou, A., Pagliaro, P., Stensløkken, K., García‐Dorado, D., & (CA16225), T. E. C. A. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15127 · Cited by 206 · see citing works
Feng, J., Wang, X., Ye, X., Arés, I., López-Torres, B., Martínez, M., Martínez‐Larrañaga, M., Wang, X., Anadón, A., & Martínez, M. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106114 · Cited by 198 · see citing works
Zhang, Y., Li, M., Wang, Y., Han, F., Shen, K., Luo, L., Li, Y., Jia, Y., Zhang, J., Cai, W., et al. (2023) · Bioactive Materials · doi:10.1016/j.bioactmat.2023.01.020 · Cited by 158 · see citing works
Calabrese, V., Giordano, J., Signorile, A., Ontario, M. L., Castorina, S., Pasquale, C. D., Eckert, G. P., & Calabrese, E. J. (2016) · Journal of Neuroscience Research · doi:10.1002/jnr.23925 · Cited by 156 · see citing works
AMP-Activated Protein Kinase Regulation of the NLRP3 Inflammasome during Aging
Cordero, M. D., Williams, M. R., & Ryffel, B. (2017) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2017.10.009 · Cited by 147 · see citing works
Effects of antidiabetic drugs on NLRP3 inflammasome activity, with a focus on diabetic kidneys
Yaribeygi, H., Katsiki, N., Butler, A. E., & Sahebkar, A. (2018) · Drug Discovery Today · doi:10.1016/j.drudis.2018.08.005 · Cited by 141 · see citing works
Metformin as an anti-inflammatory agent: a short review
Kristófi, R., & Eriksson, J. W. (2021) · Journal of Endocrinology · doi:10.1530/joe-21-0194 · Cited by 137 · see citing works
Lao, A., Wu, J., Li, D., Shen, A., Li, Y., Zhuang, Y., Lin, K., Wu, J., & Liu, J. (2023) · Small · doi:10.1002/smll.202206919 · Cited by 123 · see citing works
The Roles of Endoplasmic Reticulum in NLRP3 Inflammasome Activation
Zhou, Y., Tong, Z., Jiang, S., Zheng, W., Zhao, J.-J., & Zhou, X.-M. (2020) · Cells · doi:10.3390/cells9051219 · Cited by 114 · see citing works
Diabetes Mellitus, Mitochondrial Dysfunction and Ca2+-Dependent Permeability Transition Pore
Belosludtsev, K. N., Belosludtseva, N. V., & Dubinin, M. V. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186559 · Cited by 122 · see citing works
The Effect of Resveratrol on the Cardiovascular System from Molecular Mechanisms to Clinical Results
Gál, R., Deres, L., Tóth, K., Halmosi, R., & Habon, T. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221810152 · Cited by 116 · see citing works
Su, M., Zhao, W., Xu, S., & Weng, J. (2022) · Antioxidants · doi:10.3390/antiox11061085 · Cited by 120 · see citing works
Prattichizzo, F., Giuliani, A., Mensa’, E., Sabbatinelli, J., Nigris, V. D., Rippo, M. R., Sala, L. L., Procopio, A. D., Olivieri, F., & Ceriello, A. (2018) · Ageing Research Reviews · doi:10.1016/j.arr.2018.10.003 · Cited by 111 · see citing works
Stressing out the mitochondria: Mechanistic insights into NLRP3 inflammasome activation
Yabal, M., Calleja, D. J., Simpson, D. S., & Lawlor, K. E. (2018) · Journal of Leukocyte Biology · doi:10.1002/jlb.mr0318-124r · Cited by 109 · see citing works
Yang, L., Li, X., Jiang, A., Li, X., Chang, W., Chen, J., & Ye, F. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101626 · Cited by 110 · see citing works
ER stress and inflammation crosstalk in obesity
Ajoolabady, A., Lebeaupin, C., Wu, N. N., Kaufman, R. J., & Ren, J. T. (2022) · Medicinal Research Reviews · doi:10.1002/med.21921 · Cited by 106 · see citing works
Pellegrini, C., Fornai, M., Antonioli, L., Blandizzi, C., & Calderone, V. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20122876 · Cited by 110 · see citing works
NLRP3 Inflammasome Activation in Adipose Tissues and Its Implications on Metabolic Diseases
Wu, K. K.-L., Cheung, S. W. M., & Cheng, K. K. Y. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21114184 · Cited by 104 · see citing works
Mitochondrial Dysfunction in Cardiovascular Diseases: Potential Targets for Treatment
Yang, J., Guo, Q., Feng, X., Liu, Y., & Zhou, Y. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.841523 · Cited by 102 · see citing works
Diabetes Mellitus Promotes the Development of Atherosclerosis: The Role of NLRP3
Ye, J., Li, L., Wang, M., Ma, Q., Tian, Y., Zhang, Q., Liu, J., Li, B., Zhang, B., Liu, H., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.900254 · Cited by 100 · see citing works
Mitochondrial-Shaping Proteins in Cardiac Health and Disease – the Long and the Short of It!
Ong, S., Kalkhoran, S. B., Hernández‐Reséndiz, S., Samangouei, P., Ong, S., & Hausenloy, D. J. (2017) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-016-6710-1 · Cited by 99 · see citing works
NLRP3 Inflammasome Activation: A Therapeutic Target for Cerebral Ischemia–Reperfusion Injury
Wang, L., Ren, W., Wu, Q., Liu, T., Wei, Y. L., Ding, J., Zhou, C., Xu, H., & Yang, S. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.847440 · Cited by 100 · see citing works
Xu, L., Yan, X., Zhao, Y., Song, J., Liu, B., Yu, S., Fu, J., Liu, Y., & Su, J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23169252 · Cited by 102 · see citing works
Zhang, Q., Hu, C., Huang, J., Liu, W., Lai, W., Leng, F., Tang, Q., Liu, Y., Wang, Q., Zhou, M., et al. (2019) · Experimental & Molecular Medicine · doi:10.1038/s12276-019-0318-z · Cited by 96 · see citing works
Metformin enhances mitochondrial biogenesis and thermogenesis in brown adipocytes of mice
Karise, I., Bargut, T. C. L., del Sol, M., Águila, M. B., & Mandarim‐de‐Lacerda, C. A. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.01.021 · Cited by 92 · see citing works
Effect and Regulation of the NLRP3 Inflammasome During Renal Fibrosis
Zhang, H., & Wang, Z. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2019.00379 · Cited by 87 · see citing works
Tüfekçi, K. U., Eltutan, B. I., Isci, K. B., & Genç, Ş. (2021) · Neurotoxicity Research · doi:10.1007/s12640-021-00435-w · Cited by 87 · see citing works
RIP1-RIP3-DRP1 pathway regulates NLRP3 inflammasome activation following subarachnoid hemorrhage
Zhou, K., Shi, L., Wang, Z., Zhou, J., Manaenko, A., Reis, C., Chen, S., & Zhang, J. (2017) · Experimental Neurology · doi:10.1016/j.expneurol.2017.06.003 · Cited by 86 · see citing works
Mitochondrial Dysfunction, Oxidative Stress, and Inter-Organ Miscommunications in T2D Progression
Veluthakal, R., Esparza, D., Hoolachan, J. M., Balakrishnan, R., Ahn, M., Oh, E., Jayasena, C. S., & Thurmond, D. C. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25031504 · Cited by 90 · see citing works
Mitochondrial oxidative stress in obesity: role of the mineralocorticoid receptor
Lefranc, C., Friederich‐Persson, M., Palacios, R., & Cat, A. N. D. (2018) · Journal of Endocrinology · doi:10.1530/joe-18-0163 · Cited by 79 · see citing works
Lipid regulation of NLRP3 inflammasome activity through organelle stress
Liang, J. J., Fraser, I. D. C., & Bryant, C. E. (2021) · Trends in Immunology · doi:10.1016/j.it.2021.07.005 · Cited by 75 · see citing works
Zhou, T., Zhang, S.-L., He, C., Zhuang, Q.-Y., Han, P., Jiang, S., Yao, H., Huang, Y., Ling, W., Lin, Y., et al. (2017) · Theranostics · doi:10.7150/thno.17647 · Cited by 77 · see citing works
Zhang, S., Che, L., He, C., Huang, J., Guo, N., Shi, J., Lin, Y., & Lin, Z. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1730-y · Cited by 75 · see citing works
Differential role of the NLRP 3 inflammasome in infection and tumorigenesis
Tartey, S., & Kanneganti, T. (2019) · Immunology · doi:10.1111/imm.13046 · Cited by 73 · see citing works
Zhang, J., Wang, Y., Liu, X., Dagda, R. K., & Zhang, Y. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/4353510 · Cited by 73 · see citing works
Vazirpanah, N., Ottria, A., van der Linden, M., Wichers, C. G. K., Schuiveling, M., van Lochem, E. G., Phipps‐Green, A. J., Merriman, T. R., Zimmermann, M., Jansen, M., et al. (2019) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2018-214656 · Cited by 70 · see citing works
Tang, G., Duan, F., Li, W., Wang, Y., Zeng, C., Hu, J., Li, H., Zhang, X., Chen, Y., & Tan, H. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109410 · Cited by 70 · see citing works
Metformin alleviates renal injury in diabetic rats by inducing Sirt1/FoxO1 autophagic signal axis
Xu, J., Liu, L., Xu, L., Xing, Y., & Ye, S. (2019) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.13226 · Cited by 69 · see citing works
Yu, T., Wang, L., Zhang, L., & Deuster, P. A. (2023) · Antioxidants · doi:10.3390/antiox12061163 · Cited by 71 · see citing works
Divergent Effects of Metformin on an Inflammatory Model of Parkinson’s Disease
Tayara, K., Espinosa‐Oliva, A. M., García-Domínguez, I., Ismaiel, A. A., Boza‐Serrano, A., Deierborg, T., Machado, A., Herrera, A. J., Venero, J. L., & de Pablos, R. M. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00440 · Cited by 66 · see citing works
Domingues, A., Jolibois, J., Marquet, P., & Nivet‐Antoine, V. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22041693 · Cited by 72 · see citing works
Ram, C., Jha, A. K., Ghosh, A., Gairola, S., Syed, A. M., Murty, U. S., Naidu, V. G. M., & Sahu, B. D. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173503 · Cited by 64 · see citing works
Inhibitory effects of phytochemicals on NLRP3 inflammasome activation: A review
Olcum, M., Tastan, B., Ercan, İ., Eltutan, B. I., & Genç, Ş. (2020) · Phytomedicine · doi:10.1016/j.phymed.2020.153238 · Cited by 63 · see citing works
Pal, P. B., Sonowal, H., Shukla, K., Sk, S., & Ramana, K. V. (2017) · Endocrinology · doi:10.1210/en.2017-00294 · Cited by 63 · see citing works
Remodeling of Mitochondrial Plasticity: The Key Switch from NAFLD/NASH to HCC
Longo, M., Paolini, E., Meroni, M., & Dongiovanni, P. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22084173 · Cited by 61 · see citing works
The Mechanism and Regulation of the NLRP3 Inflammasome during Fibrosis
Artlett, C. M. (2022) · Biomolecules · doi:10.3390/biom12050634 · Cited by 61 · see citing works
Recent advances of hydrogels as smart dressings for diabetic wounds
Wang, X., Yang, Y., Zhao, W., Zhu, Z., & Pei, X. (2024) · Journal of Materials Chemistry B · doi:10.1039/d3tb02355a · Cited by 61 · see citing works
Mitochondrial regulation of diabetic vascular disease: an emerging opportunity
Widlansky, M. E., & Hill, R. B. (2018) · Translational research · doi:10.1016/j.trsl.2018.07.015 · Cited by 57 · see citing works
Medicinal plants and bioactive natural products as inhibitors of NLRP3 inflammasome
Bagherniya, M., Khedmatgozar, H., Fakheran, O., Xu, S., Johnston, T. P., & Sahebkar, A. (2021) · Phytotherapy Research · doi:10.1002/ptr.7118 · Cited by 58 · see citing works
Promise of the NLRP3 Inflammasome Inhibitors in In Vivo Disease Models
Das, B., Sarkar, C., Rawat, V. S., Kalita, D., Deka, S., & Agnihotri, A. (2021) · Molecules · doi:10.3390/molecules26164996 · Cited by 58 · see citing works
Right place, right time: localisation and assembly of the NLRP3 inflammasome
Hamilton, C., & Anand, P. (2019) · F1000Research · doi:10.12688/f1000research.18557.1 · Cited by 53 · see citing works
The NLPR3 inflammasome and obesity‐related kidney disease
Ke, B., Shen, W., Fang, X., & Wu, Q. (2017) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13333 · Cited by 54 · see citing works
Rudokas, M. W., McKay, M., Toksoy, Z., Eisen, J. N., Bögner, M., Young, L. H., & Akar, F. G. (2024) · Cardiovascular Diabetology · doi:10.1186/s12933-024-02357-1 · Cited by 55 · see citing works
Negative regulators and their mechanisms in NLRP3 inflammasome activation and signaling
Kim, J. K., Jin, H. S., Suh, H., & Jo, E. (2017) · Immunology and Cell Biology · doi:10.1038/icb.2017.23 · Cited by 53 · see citing works
Olivares-Vicente, M., & Herranz-López, M. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26178544 · Cited by 59 · see citing works
Liu, H., Xiang, H., Zhao, S., Sang, H., Lv, F., Chen, R., Shu, Z., Chen, A. F., Chen, S., & Lu, H. (2019) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13975 · Cited by 52 · see citing works
Dosis Facit Sanitatem—Concentration-Dependent Effects of Resveratrol on Mitochondria
Madreiter‐Sokolowski, C. T., Sokolowski, A., & Graier, W. F. (2017) · Nutrients · doi:10.3390/nu9101117 · Cited by 52 · see citing works
Natural antioxidants’ effects on endoplasmic reticulum stress-related diseases
Reyes-Fermín, L. M., Aparicio-Trejo, O. E., Avila-Rojas, S. H., Gómez-Sierra, T., Martínez-Klimova, E., & Pedraza-Chaverri, J. (2020) · Food and Chemical Toxicology · doi:10.1016/j.fct.2020.111229 · Cited by 50 · see citing works
Pham, D., Raut, P. K., Pandit, M., Chang, J., Katila, N., Choi, D., Jeong, J., & Park, P. (2020) · Cancers · doi:10.3390/cancers12030613 · Cited by 50 · see citing works
Phytochemical inhibitors of the NLRP3 inflammasome for the treatment of inflammatory diseases
Özenver, N., & Efferth, T. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105710 · Cited by 54 · see citing works
Bañuls, C., Rovira-Llopis, S., Lopez-Domenech, S., Diaz-Morales, N., Blas-Garcia, A., Veses, S., Morillas, C., Victor, V. M., Rocha, M., & Hernandez-Mijares, A. (2017) · International Journal of Obesity · doi:10.1038/ijo.2017.147 · Cited by 47 · see citing works
Zhou, X., Zhang, P., Wang, Q., Ji, N., Xia, S., Ding, Y., & Wang, Q. (2019) · Journal of Periodontology · doi:10.1002/jper.18-0528 · Cited by 47 · see citing works
Thioredoxin-Interacting Protein in Cancer and Diabetes
Masutani, H. (2021) · Antioxidants and Redox Signaling · doi:10.1089/ars.2021.0038 · Cited by 46 · see citing works
The Mitochondria: A Target of Polyphenols in the Treatment of Diabetic Cardiomyopathy
Bhagani, H., Nasser, S. A., Dakroub, A. H., EL‐Yazbi, A. F., Eid, A. A., Kobeissy, F. H., Pintus, G., & Eid, A. H. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21144962 · Cited by 45 · see citing works
Zhang, L., Lu, L., Zhong, X., Yue, Y., Hong, Y., Li, Y., & Li, Y. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.03.006 · Cited by 44 · see citing works
Elamipretide Attenuates Pyroptosis and Perioperative Neurocognitive Disorders in Aged Mice
Zuo, Y., Yin, L., Cheng, X., Li, J., Wu, H., Liu, X., Gu, E., & Wu, J. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00251 · Cited by 45 · see citing works
Mohamed, I., Li, L., Ismael, S., Ishrat, T., & El‐Remessy, A. B. (2021) · World Journal of Diabetes · doi:10.4239/wjd.v12.i12.1979 · Cited by 43 · see citing works
Hu, H., Fan, X., Yin, Y., Guo, Q., Yang, D., Wei, X., Zhang, B., Liu, J., Wu, Q., Oh, Y., et al. (2019) · Environmental Toxicology · doi:10.1002/tox.22823 · Cited by 43 · see citing works
Zhou, Y., Suo, W., Zhang, X., Liang, J., Zhao, W., Wang, Y., Li, H., & Ni, Q. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115669 · Cited by 43 · see citing works
Ji, T., Han, Y., Yang, W., Xu, B., Sun, M., Jiang, S., Yu, Y., Jin, Z., Ma, Z.-Q., Yang, Y., et al. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28275 · Cited by 41 · see citing works
Mitochondrial DNA and Inflammation in Alzheimer’s Disease
Galizzi, G., & Carlo, M. D. (2023) · Current Issues in Molecular Biology · doi:10.3390/cimb45110540 · Cited by 42 · see citing works
Li, D., Zhang, T., Lu, J., Peng, C. Y., & Lin, L. (2020) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2020.1768044 · Cited by 41 · see citing works
Satheesan, A., Kumar, J. S., Leela, K. V., Murugesan, R., Chaithanya, V., & Angelin, M. (2024) · Inflammopharmacology · doi:10.1007/s10787-024-01556-2 · Cited by 40 · see citing works
Chang, E. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231810915 · Cited by 39 · see citing works
Targeting Mitochondrial Network Architecture in Down Syndrome and Aging
Mollo, N., Cicatiello, R., Aurilia, M., Scognamiglio, R., Genesio, R., Charalambous, M., Paladino, S., Conti, A. M. F., Nitsch, L., & Izzo, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21093134 · Cited by 39 · see citing works
Lepez, A., Pirnay, T., Denanglaire, S., Pérez-Morga, D. L., Vermeersch, M., Léo, O., & Andris, F. (2020) · Scientific Reports · doi:10.1038/s41598-020-78715-2 · Cited by 38 · see citing works
Insights by which TUDCA is a potential therapy against adiposity
Freitas, I. N., junior, J. A. D. S., de Oliveira, K. M., Alves, B. L., Araújo, T. R., Camporez, J. P., Carneiro, E. M., & Davel, A. P. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1090039 · Cited by 39 · see citing works
Behl, T., Makkar, R., Anwer, M. K., Hassani, R., Khuwaja, G., Khalid, A., Mohan, S., Alhazmi, H. A., Sachdeva, M., & Rachamalla, M. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12082882 · Cited by 38 · see citing works
Li, F., Yang, Y., Yang, L., Wang, K., Zhang, X., Zong, Y., Ding, Y., Wang, C., Zhang, L., & Ji, G. (2017) · Oncotarget · doi:10.18632/oncotarget.16460 · Cited by 38 · see citing works
The Effects of Metformin on Obesity-Induced Dysfunctional Retinas
Kim, A. J., Chang, J. Y.-A., Shi, L., Chang, R. C.-A., Ko, M. L., & Ko, G. Y.-P. (2017) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.16-20691 · Cited by 38 · see citing works
Adaptations of Skeletal Muscle Mitochondria to Obesity, Exercise, and Polyunsaturated Fatty Acids
Chen, P. B., Yang, J. S., & Park, Y. (2018) · Lipids · doi:10.1002/lipd.12037 · Cited by 37 · see citing works
Ahmadi, A., Hayes, A. W., & Karimi, G. (2021) · Phytotherapy Research · doi:10.1002/ptr.7192 · Cited by 36 · see citing works
Dludla, P. V., Silvestri, S., Orlando, P., Gabuza, K., Mazibuko-Mbeje, S. E., Nyambuya, T. M., Mxinwa, V., Mokgalaboni, K., Johnson, R., Muller, C. J. F., et al. (2020) · Nutrients · doi:10.3390/nu12030739 · Cited by 35 · see citing works
Macrophage and Adipocyte Mitochondrial Dysfunction in Obesity-Induced Metabolic Diseases
Wang, L., Hu, J., & Zhou, H. (2020) · The World Journal of Men s Health · doi:10.5534/wjmh.200163 · Cited by 35 · see citing works
The Aged Intestine: Performance and Rejuvenation
Wang, Q., Qi, Y., Shen, W., Xu, J., Wang, L., Chen, S., Hou, T., & Si, J. (2021) · Aging and Disease · doi:10.14336/ad.2021.0202 · Cited by 35 · see citing works
Palee, S., Higgins, L., Leech, T., Chattipakorn, S. C., & Chattipakorn, N. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110604 · Cited by 36 · see citing works
RetractedWang, Y., Wang, J., Tao, S., Liang, Z., xie, R., Liu, N., Deng, R., Zhang, Y., Deng, D., & Jiang, G. (2023) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3733 · Cited by 35 · see citing works
Abad‐Jiménez, Z., López‐Domènech, S., Díaz‐Rúa, R., Iannantuoni, F., Gómez‐Abril, S. Á., Periañez-Gómez, D., Morillas, C., Víctor, V. M., & Rocha, M. (2020) · Antioxidants · doi:10.3390/antiox9090892 · Cited by 33 · see citing works
- Authors
- Li, A., Zhang, S., Li, J., Liu, K., Huang, F., & Liu, B.
- Affiliations
- China Pharmaceutical University (CN)
- Corresponding author
- Liu, Baolin
- Venue
- Molecular and Cellular Endocrinology
- Publisher
- Elsevier BV
- Published
- 2016-10
- Volume
- 434
- Pages
- 36-47
- ISSN
- 0303-7207 (ISSN-L)
- OpenAlex
- W2428504347
- Cited by
- 197
- References
- 28
- Citations by year
- 2026: 12 · 2025: 14 · 2024: 13 · 2023: 21 · 2022: 21 · 2021: 29 · 2020: 33 · 2019: 18 · 2018: 13 · 2017: 18 · 2016: 4
- FWCI
- 9.18
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Molecular and Cellular Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Pharmaceutical University, Nanjing, China
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Health Sciences › Medicine › Physiology › Adipose Tissue and Metabolism
- Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
- Keywords
- metformin, resveratrol, Drp1, mitochondrial fission, endoplasmic reticulum stress, NLRP3 inflammasome, TXNIP, AMPK, adipose tissue dysfunction, high glucose, type 2 diabetes, IRE1α, eIF2α, reactive oxygen species, adipocyte apoptosis, tauroursodeoxycholic acid
- MeSH terms
- NLR Family, Pyrin Domain-Containing 3 Protein, Resveratrol, Adipose Tissue, Animals, Cell Differentiation, Diabetes Mellitus, Experimental, Gene Expression Regulation, Metformin, Mitochondria, Phosphorylation, Stilbenes, Apoptosis, Reactive Oxygen Species, Dynamins, 3T3-L1 Cells, Mice, Inflammasomes, Endoplasmic Reticulum Stress, Mitochondrial Dynamics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review